456 related articles for article (PubMed ID: 32766196)
21. Hospitalized patients with diarrhea: Rate of Clostridioides difficile infection underdiagnosis and drivers of clinical suspicion.
Cataldo MA; Granata G; D'Arezzo S; Tonziello G; Vulcano A; De Giuli C; Meledandri M; Di Caro A; Petrosillo N
Anaerobe; 2021 Aug; 70():102380. PubMed ID: 33971317
[TBL] [Abstract][Full Text] [Related]
22. Clinical Presentations, Predictive Factors, and Outcomes of Clostridioides difficile Infection among COVID-19 Hospitalized Patients—A Single Center Experience from the COVID Hospital of the University Clinical Center of Vojvodina, Serbia.
Kovačević N; Lendak D; Popović M; Plećaš Đuric A; Pete M; Petrić V; Sević S; Tomić S; Alargić J; Damjanov D; Kosjer D; Lekin M
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143939
[No Abstract] [Full Text] [Related]
23. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.
Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH;
Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194
[TBL] [Abstract][Full Text] [Related]
24. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
[TBL] [Abstract][Full Text] [Related]
25. A new score to predict Clostridioides difficile infection in medical patients: a sub-analysis of the FADOI-PRACTICE study.
Mumoli N; Bonaventura A; Marchesi C; Cei M; Morbidoni L; Donatiello I; Mazzone A; Dentali F
Intern Emerg Med; 2023 Oct; 18(7):2003-2009. PubMed ID: 37633862
[TBL] [Abstract][Full Text] [Related]
26. Significance of Clostridium difficile in community-acquired diarrhea in a tertiary care center in Lebanon.
Al Assaad R; Dakessian A; Bachir R; Bizri AR; El Sayed M
Sci Rep; 2020 Mar; 10(1):5678. PubMed ID: 32231237
[TBL] [Abstract][Full Text] [Related]
27. Frequency of Diarrhea, Stool Specimen Collection and Testing, and Detection of Clostridioides Difficile Infection Among Hospitalized Adults in the Muenster/Coesfeld Area, Germany.
Effelsberg N; Buchholz M; Kampmeier S; Lücke A; Schwierzeck V; Angulo FJ; Brestrich G; Martin C; Moïsi JC; von Eiff C; Mellmann A; von Müller L
Curr Microbiol; 2022 Dec; 80(1):37. PubMed ID: 36526801
[TBL] [Abstract][Full Text] [Related]
28. Factors predictive of severe Clostridium difficile infection depend on the definition used.
Khanafer N; Barbut F; Eckert C; Perraud M; Demont C; Luxemburger C; Vanhems P
Anaerobe; 2016 Feb; 37():43-8. PubMed ID: 26335160
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for complicated course and recurrence of Clostridioides Difficile infections during COVID-19 pandemic.
Bednarska A; Sosińska-Bryła I; Hackiewicz M; Bursa D; Makowiecki M; Porowski D; Horban A
Przegl Epidemiol; 2022; 77(1):23-33. PubMed ID: 37283245
[TBL] [Abstract][Full Text] [Related]
30. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.
Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941
[TBL] [Abstract][Full Text] [Related]
31. Incidence, outcome, and risk factors for recurrence of nosocomial Clostridioides difficile infection in adults: A prospective cohort study.
Karaoui WR; Rustam LBO; Bou Daher H; Rimmani HH; Rasheed SS; Matar GM; Mahfouz R; Araj GF; Zahreddine N; Kanj SS; Berger FK; Gärtner B; El Sabbagh R; Sharara AI
J Infect Public Health; 2020 Apr; 13(4):485-490. PubMed ID: 31838001
[TBL] [Abstract][Full Text] [Related]
32. Hospital acquired Clostridioides difficile infection and risk factors for severity in a university hospital: A prospective study.
Bilgin H; Sayın E; Gürün HP; Tükenmez-Tigen E; Ülger Toprak N; Korten V
Am J Infect Control; 2020 Dec; 48(12):1426-1430. PubMed ID: 32522607
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile infection in an endemic setting in the Netherlands.
Hensgens MP; Goorhuis A; van Kinschot CM; Crobach MJ; Harmanus C; Kuijper EJ
Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):587-93. PubMed ID: 21194003
[TBL] [Abstract][Full Text] [Related]
34. A Cross-Sectional Study of Clostridium Difficile Infection in Inpatients with Antibiotic Associated Diarrhea.
Ma X; Li Z; Zheng Y; Fang L; Lin H; Xu H; Hong G
Clin Lab; 2023 Apr; 69(4):. PubMed ID: 37057925
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.
Vesteinsdottir I; Gudlaugsdottir S; Einarsdottir R; Kalaitzakis E; Sigurdardottir O; Bjornsson ES
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2601-10. PubMed ID: 22441775
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Clostridium difficile-suspected diarrhea in a French university hospital.
Khanafer N; Vanhems P; Barbut F; Eckert C; Perraud M; Vandenesch F; Luxemburger C; Demont C;
Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2123-2130. PubMed ID: 30120646
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors, Clinical Characteristics, and Treatment Differences Between Residents With and Without Nursing Home- and Non-Nursing Home-Acquired Clostridium difficile Infection.
Zarowitz BJ; Allen C; O'Shea T; Strauss ME
J Manag Care Spec Pharm; 2015 Jul; 21(7):585-95. PubMed ID: 26108383
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
Barletta JF; Sclar DA
Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
[TBL] [Abstract][Full Text] [Related]
40. Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI).
Manthey CF; Dranova D; Christner M; Drolz A; Kluge S; Lohse AW; Fuhrmann V
Crit Care; 2019 Dec; 23(1):399. PubMed ID: 31815650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
